184 related articles for article (PubMed ID: 37683978)
21. Comparison of 21-gene assay and St.Gallen International Expert Consensus in the treatment decision for patients with early invasive breast cancers.
Luo M; Li F; Su K; Yuan H; Zeng J
Cancer Biol Ther; 2020; 21(2):108-112. PubMed ID: 31663437
[TBL] [Abstract][Full Text] [Related]
22. Highlights of the 17th St Gallen International Breast Cancer Conference 2021: customising local and systemic therapies.
Reinert T; de Souza ABA; Sartori GP; Obst FM; Barrios CH
Ecancermedicalscience; 2021; 15():1236. PubMed ID: 34221119
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant strategies in breast cancer: new prospectives, questions and reflections at the end of 2007 St Gallen International Expert Consensus Conference.
Cinieri S; Orlando L; Fedele P; Cusmai A; D'Amico M; Rizzo P; Chetri MC
Ann Oncol; 2007 Jun; 18 Suppl 6():vi63-5. PubMed ID: 17591835
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant treatment of breast cancer in 2004. A review of the 8th consensus conference of St. Gallen and new study results].
Kahlert S; von Koch F; Ditsch N; Untch M
Gynakol Geburtshilfliche Rundsch; 2004 Apr; 44(2):102-12. PubMed ID: 15073439
[TBL] [Abstract][Full Text] [Related]
26. Risk of Positive Sentinel Lymph Node After Neoadjuvant Systemic Therapy in Clinically Node-Negative Breast Cancer: Implications for Postmastectomy Radiation Therapy and Immediate Breast Reconstruction.
Samiei S; van Kaathoven BN; Boersma L; Granzier RWY; Siesling S; Engelen SME; de Munck L; van Kuijk SMJ; van der Hulst RRJW; Lobbes MBI; Smidt ML; van Nijnatten TJA
Ann Surg Oncol; 2019 Nov; 26(12):3902-3909. PubMed ID: 31359276
[TBL] [Abstract][Full Text] [Related]
27. Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus Conference.
Untch M; Fasching PA; Brucker SY; Budach W; Denkert C; Haidinger R; Huober J; Jackisch C; Janni W; Kolberg-Liedtke C; Krug D; Kühn T; Loibl S; Lüftner D; Müller V; Schneeweiss A; Thill M; Harbeck N; Thomssen C
Geburtshilfe Frauenheilkd; 2021 Jun; 81(6):637-653. PubMed ID: 34168378
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy statements of the 18th St. Gallen International Breast Cancer Consensus Conference-a German expert perspective.
Krug D; Banys-Paluchowski M; Brucker SY; Denkert C; Ditsch N; Fasching PA; Haidinger R; Harbeck N; Heil J; Huober J; Jackisch C; Janni W; Kolberg HC; Loibl S; Lüftner D; van Mackelenbergh M; Radosa JC; Reimer T; Welslau M; Würstlein R; Untch M; Budach W
Strahlenther Onkol; 2024 Jun; 200(6):461-467. PubMed ID: 38393398
[TBL] [Abstract][Full Text] [Related]
29. Treatment of Early Breast Cancer: The 18th St. Gallen International Breast Cancer Consensus Conference against the Background of Current German Treatment Recommendations.
Untch M; Banys-Paluchowski M; Brucker SY; Budach W; Denkert C; Ditsch N; Fasching PA; Haidinger R; Heil J; Jackisch C; Janni W; Kolberg HC; Krug D; Loibl S; Lüftner D; van Mackelenbergh M; Radosa JC; Reimer T; Welslau M; Würstlein R; Harbeck N; Huober J
Geburtshilfe Frauenheilkd; 2023 Sep; 83(9):1102-1116. PubMed ID: 37706057
[TBL] [Abstract][Full Text] [Related]
30. Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus.
Khaled H; Nada YW; Ramadan KM; Fekry S; Seleam MS; Gaafar R; Lotayef M
J Egypt Natl Canc Inst; 2022 Dec; 34(1):56. PubMed ID: 36567400
[TBL] [Abstract][Full Text] [Related]
31. Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controversial issues in the primary treatment of rectal cancer.
Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
Eur J Cancer; 2016 Aug; 63():11-24. PubMed ID: 27254838
[TBL] [Abstract][Full Text] [Related]
32. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
33. St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer.
Thomssen C; Balic M; Harbeck N; Gnant M
Breast Care (Basel); 2021 Apr; 16(2):135-143. PubMed ID: 34002112
[TBL] [Abstract][Full Text] [Related]
34. Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.
Kolberg-Liedtke C; Lüftner D; Brucker SY; Budach W; Denkert C; Fasching PA; Haidinger R; Harbeck N; Huober J; Jackisch C; Janni W; Krug D; Kühn T; Loibl S; Müller V; Schneeweiss A; Thomssen C; Untch M; Thill M
Breast Care (Basel); 2022 Jun; 17(3):336-345. PubMed ID: 35957945
[TBL] [Abstract][Full Text] [Related]
35. 8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003.
Glen H; Jones RJ
Breast Cancer Res; 2003; 5(4):198-201. PubMed ID: 12817991
[TBL] [Abstract][Full Text] [Related]
36. A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles.
Gandhi S; Brackstone M; Hong NJL; Grenier D; Donovan E; Lu FI; Skarpathiotakis M; Lee J; Boileau JF; Perera F; Simmons C; Joy AA; Tran WT;
Breast Cancer Res Treat; 2022 May; 193(1):1-20. PubMed ID: 35224713
[TBL] [Abstract][Full Text] [Related]
37. Highlights from the 13th St Gallen International Breast Cancer Conference 2013. Access to innovation for patients with breast cancer: how to speed it up?
Curigliano G; Criscitiello C; Andrè F; Colleoni M; Di Leo A
Ecancermedicalscience; 2013; 7():299. PubMed ID: 23589728
[TBL] [Abstract][Full Text] [Related]
38. Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer.
Bauer K; Parise C; Caggiano V
BMC Cancer; 2010 May; 10():228. PubMed ID: 20492696
[TBL] [Abstract][Full Text] [Related]
39. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Goldhirsch A; Wood WC; Coates AS; Gelber RD; Thürlimann B; Senn HJ;
Ann Oncol; 2011 Aug; 22(8):1736-47. PubMed ID: 21709140
[TBL] [Abstract][Full Text] [Related]
40. [Systemic treatment of early breast cancer - current state of knowledge after the conference St Gallen 2017].
Sarosiek T
Pol Merkur Lekarski; 2017 Nov; 43(257):232-236. PubMed ID: 29231918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
